Louisiana 2017 Regular Session

Louisiana House Bill HB436

Introduced

3/31/17

Introduced

3/31/17

Refer

3/31/17

Refer

3/31/17

Refer

4/10/17

Refer

4/10/17

Report Pass

5/10/17

Refer

5/11/17

Refer

5/11/17

Engrossed

5/25/17

Engrossed

5/25/17

Refer

5/30/17

Report Pass

5/31/17

Report Pass

5/31/17

Enrolled

6/4/17

Enrolled

6/4/17

Chaptered

6/14/17

Chaptered

6/14/17

Passed

6/14/17

Passed

6/14/17

Caption

Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)

Latest LA HB436 Activity

View All Events: LA 2017 Regular Session HB436

Companion Bills

No companion bills found.

Previously Filed As

LA HB277

Requires educational or marketing materials for prescription drugs directed to healthcare providers to include price information (OR SEE FISC NOTE GF EX)

LA SB368

Provides for prescription drug pricing. (8/1/26) (OR +$270,360 SG EX See Note)

LA HB920

Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)

LA SB369

Provides for prescription drug pricing. (1/1/27) (EG SG EX See Note)

LA HB870

Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

LA SB243

Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

LA HB3086

Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

LA HB606

Exempts prescription drugs and insulin from local sales and use taxes (EG DECREASE LF RV See Note)

LA SB401

Provides for a Prescription Drug Affordability Board. (8/1/26)

LA SB289

Relating to prescription drugs.

Similar Bills

No similar bills found.